Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1959414Generated: November 2, 2026

1-(2-(Methylsulfonyl)ethyl)piperazine → tert-butyl N-tert-butoxylcarbonyl-5-(4-(2-(methylsulfonyl)ethyl)piperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-ylcarbamate

https://huagongshe.com/reaction/1959414

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-(2-(Methylsulfonyl)ethyl)piperazineHCID 3801959—
ReactantTert-butyl N-[5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-N-tert-butoxycarbonyl-carbamateHCID 59471994—
SolventDimethylformamideHCID 6228—
Producttert-butyl N-tert-butoxylcarbonyl-5-(4-(2-(methylsulfonyl)ethyl)piperazin-1-yl)-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-ylcarbamateHCID 66745771100%

Reaction Conditions

Temperature100 °C

Reaction Steps

tert-butyl N-tert butoxycarbonyl-5-bromo-3-(5-phenyl-1,3,4-oxadiazol-2-yl)pyrazin-2-ylcarbamate (75 mg, 0.13 mmol) was dissolved in DMF (1 mL) and 1-(2-(methylsulfonyl)ethyl)piperazine (77 mg, 0.40 mmol) was added. The reaction mixture was heated at 100° C. in a sealed tube overnight. The reaction mixture was cooled to room temperature and partitioned between CH2Cl2 and water and the layers separated using a phase separation cartridge. The organic layer was concentrated in vacuo to give the product (84.01 mg, 0.13 mmol)

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08410112B2
Source datasetuspto-grants-2013_04
ORD IDord-3fd441451b424e0bb940a70424ffa81d
Source noteuspto-grants-2013_04